Cytosorbents Corp expected to post a loss of 12 cents a share - Earnings Preview

Cytosorbents

30/10/2023 11:39

* Cytosorbents Corp  CTSO.OQ   CTSO.O  is expected to show a
rise
in quarterly revenue when it reports  results 
    * The Princeton New Jersey-based  company is expected to
report  a
17.0% increase in revenue to $9.492 million from $8.11 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytosorbents Corp
is for
a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $6.25​, above​ its last closing price of $1.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.11       -0.11      -0.14     Missed  -24.4
 Mar. 31 2023  -0.13       -0.13      -0.17     Missed  -34.2
 Dec. 31 2022  -0.18       -0.17      -0.02     Beat    88.1​
 Sep. 30 2022  -0.16       -0.16      -0.28     Missed  -70.7
 ​​Jun.        -0.14       -0.13      -0.25     Missed  -86.9
 30 2022                                                
 Mar. 31 2022  -0.12       -0.12      -0.21     Missed  -71.4​
 Dec. 31 2021  -0.17       -0.13      -0.21     Missed  -58.6
 Sep. 30 2021  -0.15       -0.12      -0.15     Missed  -23.3
 This summary was machine generated October 30 at 11:39 GMT.  All
figures in US dollars  unless otherwise stated